Back to Single Peptide Protocols
Single PeptideBrain Health & Nootropics5 mg vialOnce dailyIntranasal/Subcutaneous
Semax (5 mg Vial) Dosage Protocol
Semax dosage protocol for the 5 mg vial. ACTH-derived nootropic peptide with BDNF-stimulating properties. Includes intranasal dosing guidance.
Vial Size
5 mg
Route
Intranasal or subcutaneous
Frequency
Once daily
Dose Range
200–600 mcg/day
Dosage Schedule
| Period | Dose |
|---|---|
| Weeks 1–2 (starter) | 200–400 mcg |
| Weeks 3+ (maintenance) | 400–600 mcg |
Route: Intranasal or subcutaneous · Frequency: Once daily · Cycle: 2–4 weeks
How It Works
Semax is a synthetic heptapeptide derived from ACTH(4-7) that stimulates BDNF and NGF production, enhances dopaminergic and serotonergic neurotransmission, and has neuroprotective properties.
Potential Benefits
- •Stimulates BDNF and NGF production.
- •Enhances cognitive function and memory in research models.
- •Neuroprotective properties.
- •Approved in Russia for stroke and cognitive impairment.
Side Effects & Risks
- •Generally well-tolerated.
- •Mild nasal irritation with intranasal use.
- •Possible mild anxiety at higher doses.
Important Notes
- Approved in Russia for stroke and cognitive disorders.
- Research-use only in the US/EU.
- Intranasal route preferred for convenience.
Storage Instructions
- Lyophilized: −20 °C (−4 °F).
- Once mixed: 2–8 °C; use within 14 days.
References
- [1]Dolotov OV et al. Semax, an Analog of ACTH(4-7) with Cognitive Effects, Regulates BDNF and trkB Expression in the Rat Hippocampus. Brain Res 2006.View Source
Research & Educational Use Only: This protocol is for educational and research purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making any decisions related to peptides or any other compounds.